GO:0016281 eukaryotic translation initiation factor 4F complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016281 describes the eukaryotic translation initiation factor 4F (eIF4F) complex, a three-subunit assembly of eIF4E, eIF4A and eIF4G that recognizes the mRNA 5' cap, unwinds 5'-terminal secondary structure and recruits mRNA to the ribosome.
• The eIF4F complex is a convergence point for growth-signaling and stress pathways, including mTORC1-dependent control of translation initiation.
• eIF4F components are hijacked or restricted by diverse viruses, making the complex a host-dependency node in infection biology.
• Dysregulated eIF4F activity contributes to cancer and hematopoietic malignancy, and the complex is being explored as a therapeutic target.
• Structural and biochemical studies have revealed independent roles for the helicase eIF4A within human translation initiation complexes.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of eIF4F subunit function in health and disease.
Description
The eukaryotic translation initiation factor 4F complex (eIF4F) is a conserved cellular component that sits at the rate-limiting step of cap-dependent protein synthesis. According to the Gene Ontology, GO:0016281 comprises eIF4E, eIF4A and eIF4G and is involved in recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure, and recruitment of mRNA to the ribosome. Because translation initiation determines which mRNAs are translated and how efficiently, the eIF4F complex is central to gene-expression control in normal physiology and disease. For researchers, GO:0016281 is more than a static annotation: it defines a dynamic, regulated machine whose subunit composition, post-translational modifications and interaction partners determine translational output. The complex is targeted by signaling pathways such as mTORC1 and is manipulated by viruses, and its subunits are recurrently altered in cancer. Understanding eIF4F therefore requires integrating structural biology, functional genomics and disease models. This article summarizes the QuickGO definition of GO:0016281, its subunit architecture, molecular mechanism, regulation, disease relevance and the experimental methods, including CRISPR-based models, used to study it.
eukaryotic translation initiation factor 4F complex At A Glance
| GO ID | GO:0016281 |
|---|---|
| GO term | eukaryotic translation initiation factor 4F complex |
| Ontology | cellular_component |
| Synonym | cytoplasmic cap-binding complex; eIF-4F; eukaryotic translation initiation factor 4 complex |
| Major function | mRNA cap recognition, ATP-dependent 5'-terminal secondary structure unwinding, and mRNA recruitment to the ribosome |
| Core subunits | eIF4E (cap-binding), eIF4A (DEAD-box helicase), eIF4G (scaffold) |
| Associated factors | eIF4B, eIF4H, PABP and eIF3 interact with or modulate eIF4F during initiation |
| Pathway context | Cap-dependent translation initiation; regulated by mTORC1 signaling |
| Disease relevance | Cancer, hematopoietic malignancy and viral infection |
What Is GO:0016281?
GO:0016281 (eukaryotic translation initiation factor 4F complex) is a cellular component defined as a complex composed of eIF4E, eIF4A and eIF4G that recognizes the mRNA 5' cap, uses ATP to unwind 5'-terminal secondary structure, and recruits the mRNA to the ribosome. It is synonymous with the cytoplasmic cap-binding complex, eIF-4F and the eukaryotic translation initiation factor 4 complex.
Why Is eukaryotic translation initiation factor 4F complex Important in Cell Biology?
The eIF4F complex is important because it controls the committed step of cap-dependent translation, thereby shaping the proteome in response to growth, stress and immune signals. Its subunits are frequently deregulated in cancer and are required for replication of multiple viruses, making GO:0016281 a high-value annotation for both mechanistic and translational research.
• Defines the minimal cap-binding machine required for cap-dependent translation initiation.
• Integrates mTORC1 growth signaling with selective mRNA translation.
• Supports translation of mRNAs with structured 5' UTRs via eIF4A helicase activity.
• Is a host-dependency factor for viruses such as hepatitis E virus and rotavirus restriction.
• Contributes to hematopoietic malignancy through oncomicropeptide-enhanced translation initiation.
• Provides a structural paradigm for initiation complex assembly in humans.
• Offers druggable nodes (eIF4E cap binding, eIF4A helicase) for therapeutic development.
• Serves as a model for studying giant DNA virus-encoded translation initiation complexes.
• Enables CRISPR-based causal testing of subunit function in disease models.
What Happens During eukaryotic translation initiation factor 4F complex?
Cap recognition and eIF4F assembly
In simple terms: The complex first grabs the mRNA's protective cap.
eIF4E binds the m7G cap at the 5' end of mRNA, while eIF4G acts as a scaffold that bridges eIF4E to eIF4A and to other initiation factors. This assembly is the earliest committed step of cap-dependent translation and determines whether an mRNA enters the initiation pathway.
ATP-dependent 5' UTR unwinding
In simple terms: The complex uses energy to untangle the mRNA's front end.
eIF4A, a DEAD-box helicase, uses ATP to unwind secondary structure in the 5' untranslated region, assisted by eIF4B and eIF4H. Structural work on human initiation complexes has revealed two independent roles for eIF4A during initiation.
mRNA recruitment to the ribosome
In simple terms: The complex delivers the mRNA to the ribosome's starting point.
eIF4G interacts with eIF3 and the 40S ribosomal subunit, positioning the mRNA at the ribosome for start-codon selection. This recruitment step links cap recognition to ribosome engagement and is regulated by signaling inputs.
Regulation by mTORC1 signaling
In simple terms: Growth signals tell the complex when to work.
mTORC1 phosphorylates eIF4E-binding proteins (4E-BPs), releasing eIF4E to assemble into eIF4F and selectively promoting translation of growth-related mRNAs. This provides a unifying model for how nutrient and growth signals control translation initiation.
Viral subversion and host restriction
In simple terms: Viruses either use or are blocked by this complex.
The eIF4F complex restricts rotavirus infection by regulating IRF1 and IRF7 expression, whereas hepatitis E virus replication requires the complex. Giant DNA viruses can even encode a hallmark translation initiation complex of eukaryotic life, underscoring the evolutionary importance of eIF4F-like assemblies.
Key Genes Involved in GO:0016281 eukaryotic translation initiation factor 4F complex
The following genes and proteins represent the core subunits, modulators and disease-relevant partners of the eukaryotic translation initiation factor 4F complex (GO:0016281).
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF4E | Cap-binding subunit of eIF4F | Target for translation inhibition and cancer studies |
| EIF4A1 | DEAD-box helicase that unwinds 5' UTR structure | Model for helicase-dependent translation and drug targeting |
| EIF4A2 | eIF4A paralog with distinct functions | Paralog-specific knockout studies |
| EIF4G1 | Scaffold that bridges eIF4E, eIF4A and eIF3 | Central node for complex assembly and signaling |
| EIF4G2 | eIF4G family member with specialized roles | Context-dependent translation studies |
| EIF4G3 | eIF4G family member | Functional redundancy and isoform studies |
| EIF4B | Helicase cofactor enhancing eIF4A activity | Modifier of 5' UTR unwinding |
| EIF4H | Helicase cofactor | Modifier of eIF4A function |
| EIF4EBP1 | mTORC1 effector that sequesters eIF4E | Readout of mTORC1-dependent translation |
| EIF4EBP2 | 4E-BP family member | Regulation of cap-dependent translation |
| EIF3 | Interacts with eIF4G to recruit the 40S subunit | Initiation complex assembly studies |
| PABPC1 | Poly(A)-binding protein that circularizes mRNA with eIF4G | mRNA circularization and translation efficiency |
| MTOR | Kinase upstream of 4E-BP phosphorylation | Signaling-to-translation studies |
| IRF1 | Immune effector regulated by eIF4F during rotavirus infection | Host-virus interaction studies |
| IRF7 | Immune effector regulated by eIF4F during rotavirus infection | Host-virus interaction studies |
| APPLE | Oncomicropeptide enhancing translation initiation | Hematopoietic malignancy models |
How Is eukaryotic translation initiation factor 4F complex Regulated?
The eIF4F complex is regulated by mTORC1, which phosphorylates 4E-BPs to release eIF4E and promote eIF4F assembly, providing a unifying model for signal-dependent translation control. Additional layers include helicase cofactors such as eIF4B and eIF4H that modulate eIF4A activity, and viral factors that either require or restrict the complex. Post-translational modifications and interaction partners further tune eIF4F function in a context-dependent manner.
eukaryotic translation initiation factor 4F complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF4E | Cancer and hematopoietic malignancy | Knockout and overexpression cell models |
| EIF4A1 | Translation-dependent oncogenesis | Point-mutation and helicase-dead knock-in models |
| EIF4G1 | Complex assembly in cancer and infection | Knockout and tagged knock-in models |
| EIF4EBP1 | mTORC1-driven translation in disease | Phospho-mutant knock-in models |
| IRF1/IRF7 | Rotavirus restriction | Knockout and reporter models |
Cancer and hematopoietic malignancy
Dysregulated translation initiation supports oncogenic proteomes, and the oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation. eIF4F subunits are therefore candidate therapeutic targets in cancers with elevated cap-dependent translation.
Viral infection
The eIF4F complex restricts rotavirus infection by regulating IRF1 and IRF7 expression, while hepatitis E virus replication requires the complex. These opposing relationships illustrate how eIF4F can be either antiviral or proviral depending on the pathogen.
Viral evolution and host mimicry
Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life, indicating that eIF4F-like machinery is a conserved target of viral evolution. This has implications for understanding host-pathogen co-evolution and for antiviral strategies.
From eukaryotic translation initiation factor 4F complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is eIF4E required for cap-dependent translation? | EIF4E knockout cell line |
| Does eIF4A helicase activity drive 5' UTR unwinding? | EIF4A1 point-mutation (helicase-dead) knock-in |
| How does eIF4G scaffold assembly? | Tagged EIF4G1 knock-in for interaction proteomics |
| Does 4E-BP phosphorylation control eIF4F assembly? | EIF4EBP1 phospho-mutant knock-in |
| Does eIF4F restrict or support viral infection? | Knockout cells challenged with rotavirus or HEV |
| Can eIF4F drive malignancy? | Overexpression models with APPLE or eIF4E |
How to Study the eukaryotic translation initiation factor 4F complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation efficiency | Global effects of eIF4F perturbation |
| Polysome profiling | mRNA distribution across ribosomes | Cap-dependent translation activity |
| RNA-seq | Transcript abundance | Distinguishing transcription from translation |
| Affinity proteomics | Protein-protein interactions | Mapping eIF4F assembly |
| Cryo-EM | Three-dimensional structure | Mechanistic studies of initiation |
| Immunoblotting | Protein levels and phosphorylation | mTORC1-4E-BP signaling readouts |
| Reporter assays | Cap-dependent translation of a reporter | Functional testing of eIF4F subunits |
| CRISPR knockout | Loss-of-function phenotypes | Causal gene-function studies |
Ribosome profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy transcriptome-wide and can reveal how eIF4F subunits shape translation efficiency, including selective effects on mRNAs with structured 5' UTRs.
RNA-seq and translatome analysis
RNA-seq combined with polysome profiling distinguishes transcriptional from translational changes upon eIF4F perturbation, helping identify direct targets of the complex.
Proteomics and interactomics
Affinity purification and mass spectrometry of tagged eIF4F subunits define complex composition, assembly intermediates and dynamic interaction partners.
Structural biology and imaging
Cryo-EM and biochemical reconstitution have revealed the architecture of human initiation complexes and the independent roles of eIF4A. Fluorescence imaging can localize eIF4F components in cells.
How CRISPR Can Be Used to Study GO:0016281 eukaryotic translation initiation factor 4F complex
Knockout
CRISPR knockout of EIF4E, EIF4A1 or EIF4G1 can test whether each subunit is required for cap-dependent translation and for disease phenotypes such as viral replication or oncogenic growth.
Point Mutation
Point mutations that disable eIF4A helicase activity or alter eIF4E cap binding allow separation of catalytic from scaffolding functions within the complex.
Knock-in
Tagged or phospho-mutant knock-ins of eIF4G1 and EIF4EBP1 enable interaction proteomics and signaling studies in a physiological context.
Overexpression
Overexpression of eIF4E or the oncomicropeptide APPLE can model enhanced translation initiation in hematopoietic malignancy and other cancers.
How EDITGENE Supports eukaryotic translation initiation factor 4F complex Research
Researchers studying eukaryotic translation initiation factor 4F complex-related genes often need to determine whether a candidate gene is causally involved in translation control, viral restriction or oncogenesis, rather than merely correlated with a phenotype. This requires precise, reproducible genome engineering and functional readouts that can distinguish direct effects on the eIF4F complex from downstream consequences.
Contact EDITGENE today to design your custom CRISPR model for eukaryotic translation initiation factor 4F complex research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| EIF4B Knockout HEK293 Cell Line | EDJ-KQ790 | Human | 1975 | Details Get a Quote |
| EIF4E1B Knockout HEK293 Cell Line | EDJ-KQ791 | Human | 253314 | Details Get a Quote |
| EIF4E2 Knockout HEK293 Cell Line | EDJ-KQ792 | Human | 9470 | Details Get a Quote |
| EIF4G2 Knockout HEK293 Cell Line | EDJ-KQ2109 | Human | 1982 | Details Get a Quote |
| EIF4A2 Knockout HEK293 Cell Line | EDJ-KQ4510 | Human | 1974 | Details Get a Quote |
| EIF4G3 Knockout HEK293 Cell Line | EDJ-KQ6321 | Human | 8672 | Details Get a Quote |
| EIF4E3 Knockout HEK293 Cell Line | EDJ-KQ8873 | Human | 317649 | Details Get a Quote |
| OTUD6B Knockout HEK293 Cell Line | EDJ-KQ11166 | Human | 51633 | Details Get a Quote |
| EIF4A2 Knockout A-549 Cell Line | EDJ-KQ27119 | Human | 1974 | Details Get a Quote |
| EIF4A2 Knockout HCT 116 Cell Line | EDJ-KQ27120 | Human | 1974 | Details Get a Quote |
| EIF4E3 Knockout A-549 Cell Line | EDJ-KQ35193 | Human | 317649 | Details Get a Quote |
| EIF4E3 Knockout HCT 116 Cell Line | EDJ-KQ35194 | Human | 317649 | Details Get a Quote |
| OTUD6B Knockout A-549 Cell Line | EDJ-KQ39186 | Human | 51633 | Details Get a Quote |
| OTUD6B Knockout HCT 116 Cell Line | EDJ-KQ39187 | Human | 51633 | Details Get a Quote |
| OTUD6B Knockout HeLa Cell Line | EDJ-KQ39188 | Human | 51633 | Details Get a Quote |
Displaying Records 1 To 15 Of 40 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About eukaryotic translation initiation factor 4F complex
What is the eukaryotic translation initiation factor 4F complex?
It is a cellular component (GO:0016281) composed of eIF4E, eIF4A and eIF4G that recognizes the mRNA cap, unwinds 5' terminal structure and recruits mRNA to the ribosome.
What genes are involved in the eIF4F complex?
Core genes include EIF4E, EIF4A1, EIF4A2, EIF4G1, EIF4G2 and EIF4G3, with modulators such as EIF4B, EIF4H and EIF4EBP1.
What does GO:0016281 mean?
GO:0016281 is the Gene Ontology identifier for the eukaryotic translation initiation factor 4F complex, a cellular component annotation.
How is the eIF4F complex regulated?
It is regulated by mTORC1 signaling through 4E-BP phosphorylation, which controls eIF4E availability and complex assembly.
Why is eIF4F important in cancer?
Enhanced eIF4F activity supports oncogenic translation, and the oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation.
Do viruses interact with the eIF4F complex?
Yes; the complex restricts rotavirus infection via IRF1 and IRF7, while hepatitis E virus replication requires it.
What is the role of eIF4A in the complex?
eIF4A is an ATP-dependent DEAD-box helicase that unwinds 5' UTR secondary structure and has independent roles during initiation.
How can I study eIF4F with CRISPR?
Knockout, point-mutation, knock-in and overexpression models allow causal testing of subunit function in translation and disease.
What methods measure eIF4F activity?
Ribo-seq, polysome profiling, RNA-seq, affinity proteomics and reporter assays are commonly used.
Is eIF4F conserved in viruses?
Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life, indicating deep conservation of eIF4F-like machinery.
Conclusion
GO:0016281 defines the eukaryotic translation initiation factor 4F complex, a three-subunit machine that recognizes the mRNA cap, unwinds 5' terminal structure and recruits mRNA to the ribosome. Its regulation by mTORC1 and its roles in cancer and viral infection make it a central node in translation control and a compelling target for functional genomics. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with Ribo-seq and proteomics, provide the tools needed to dissect eIF4F biology and translate these insights into therapeutic strategies.
References
- 1. Brito Querido J et al.. 2024. The molecular basis of translation initiation and its regulation in eukaryotes.. Nat Rev Mol Cell Biol 25(3):168-186 PMID: 38052923
- 2. Shuvalova E et al.. 2025. Eukaryotic translation initiation factor 4F: functional properties and physiological role.. Nucleic Acids Res 53(22) PMID: 41404795
- 3. Fels JM et al.. 2026. Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life.. Cell 189(5):1423-1433.e16 PMID: 41709453
- 4. Sun L et al.. 2021. The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation.. Mol Cell 81(21):4493-4508.e9 PMID: 34555354
- 5. Chen S et al.. 2019. The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7.. Int J Mol Sci 20(7) PMID: 30934842
- 6. Brito Querido J et al.. 2024. The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A.. Nat Struct Mol Biol 31(3):455-464 PMID: 38287194
- 7. Thoreen CC et al.. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation.. Nature 485(7396):109-13 PMID: 22552098
- 8. Zhou X et al.. 2015. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.. Antiviral Res 124:11-9 PMID: 26526587
